Le Lézard
Classified in: Tourism and vacations, Health
Subject: SVY

Global Medical Tourism Market Potential 2021: Which Countries have the Highest Number of Incoming Medical Travellers and the US$ Earned


DUBLIN, Feb. 24, 2021 /PRNewswire/ -- The "Medical Tourism Global Potential 2021: Volume 1 - Background and Figures" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report will help you to understand the competition in terms of which countries have the highest number of incoming medical travellers and the US$ earned, and identify which countries have significant outgoing medical travel flows. It will give you the benefit of an impartial view of what is happening now and what the future trends may be.

2020 and 2021 have been dramatic times for medical tourism which is why it is vital for those wishing to stay or enter the market to understand not just the background but how the industry and countries are adapting.

All are essential reading if you wish to make more informed decisions and deliver a better return on your investment when targeting the international patient.

Monitoring the ever-changing world of medical tourism is a challenge for every destination and healthcare provider involved in the international patient business. Organisations must adapt their medical tourism strategy in response to a changing market. To do that, they need to know which countries are doing well or badly, who is going where, the treatments they are seeking, why they are going there, and how political, economic, social and technological changes are impacting the medical tourism market.

Key Topics Covered:

1. OVERVIEW

2. INTERNATIONAL MEDICAL TOURISM FIGURES

3. INTERNATIONAL MEDICAL TOURISM MARKET

4. MEDICAL TOURISM CUSTOMERS

5. MEDICAL TOURISM PRODUCTS AND SERVICES

6. MEDICAL TOURISM AND INSURANCE

7. EUROPEAN CROSS BORDER HEALTHCARE

8. INTERNATIONAL ORGANISATIONS

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/u1dfk6

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 08:10
Agathos Biologics, a biotechnology company developing transformational science in biomanufacturing, biologic payload delivery, and cell and gene therapy within a strong ethical and moral framework, today announced the launch of its research and...

at 08:10
Cedilla Therapeutics, a venture-backed preclinical biotechnology company developing novel small molecules for cancer and other diseases, today announced the appointment of Chris Bowden, M.D., to its Board of Directors. "Chris brings tremendous...

at 08:10
RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, appointed Yi Larson to its board of directors effective April 1, 2021. Ms. Larson has a highly accomplished biotechnology...

at 08:10
The "Hemoglobin A1C Monitoring - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Hemoglobin A1C Monitoring Market to Reach $1.7 Billion by 2027 Amid the COVID-19 crisis, the global market...

at 08:10
Apic Bio, Inc., an innovative gene therapy company developing novel treatment options for patients with rare genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application...

at 08:10
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted Cooper International and United PPE licenses...



News published on 24 february 2021 at 12:00 and distributed by: